Market Currents
Isis Pharmaceuticals (ISIS +2.9%) says it has filed a patent infringement lawsuit against...
-
Friday, September 23, 2011, 2:55 PM ETIsis Pharmaceuticals (ISIS +2.9%) says it has filed a patent infringement lawsuit against Santaris Pharma A/S based upon Santaris' activities providing antisense drugs and antisense drug discovery services to several pharmaceutical companies.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
